Related Experiment Videos

ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner

Zhiyong Ren1, Timothy S Schaefer

  • 1Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Insights

Signal transducer and activator of transcription 3 (Stat3) activation in cancer involves ErbB-2. This study reveals that JAK2 and Src kinases mediate Stat3 activation by ErbB-2, clarifying a key cancer signaling pathway.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Signal transducer and activator of transcription (Stat) proteins are key transcription factors.
  • Constitutive activation of Stat3 alpha is observed in many human cancers.
  • Stat3 activation is often linked to ErbB-2, a receptor tyrosine kinase.

Purpose of the Study:

  • To investigate the role of ErbB-2 in Stat3 activation.
  • To elucidate the molecular mechanisms underlying ErbB-2-mediated Stat3 activation.

Main Methods:

  • Utilized a constitutively activated ErbB-2 point mutant (Y-->F) at autophosphorylation sites.
  • Assessed the activation of Stat3 alpha in response to the ErbB-2 mutant.
  • Investigated the involvement of JAK2 and Src kinases in the activation pathway.

Main Results:

  • Stat3 alpha and JAK2 associate with ErbB-2 before receptor phosphorylation.
  • Full Stat3 alpha activation by ErbB-2 requires non-receptor tyrosine kinases like Src and JAK2.
  • Src binds to phosphorylated ErbB-2, and tyrosine 1139 is crucial for Src binding and Stat3 activation.

Conclusions:

  • ErbB-2 signaling pathways involve JAK2 and Src kinases in Stat3 activation.
  • Tyrosine 1139 on ErbB-2 plays a critical role in mediating Src binding and subsequent Stat3 activation.
  • Understanding this mechanism provides insights into targeted cancer therapies.

Related Concept Videos